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ABSTRACT
Introduction: Mustard gas is a known chemical weapon that was used in the 1980-1988 Iran-
Iraq War. It causes many health problems, including serious respiratory damage. In this study, we 
used high-resolution computed tomography to assess the pulmonary complications after 20 years 
of veterans of the Iran-Iraq War who were exposed to mustard gas. Materials and Methods: This 
was a follow-up study conducted on 200 Iranian veterans with a history of exposure to mustard 
gas at least 20 years previously. High-resolution computed tomography was performed on all 
veterans and was interpreted by two independent expert radiologists who were blinded to the 
study. The frequency of high-resolution computed tomography findings was reported. Data 
were analyzed with statistical package for the social sciences version 20 software. Results: One 
hundred twenty veterans (60%) showed HRCT abnormalities. The most frequent high-resolution 
computed tomography findings were diffuse hyper-aeration, 63 (52.5%); interstitial opacity, 
50 (41.7%); parenchymal opacity, 26 (21.7%); bronchiectasis, 15 (12.5%); sub-pleural air 
trapping, 13 (10.8%); and local fibrosis, 10 (8.3%). Generally, lower lobes were more frequently 
affected. Conclusion: This study showed a high frequency of abnormal high-resolution computed 
tomography findings in veterans who were exposed to mustard gas, and most abnormalities were 
irreversible. These findings included diffuse hyper-aeration, interstitial opacity, parenchymal 
opacity, bronchiectasis, sub-pleural air trapping, and local fibrosis.
INTRODUCTION
Some chemicals, which can have significant health and en-
vironmental effects, are used as warfare agents. One of the 
chemicals frequently used as a chemical weapon is mustard 
gas. Mustard gas was first used in World War I (1). In this 
war, mortality due to mustard gas was 2.5% (2). The most 
recent use of this chemical weapon was in the 1980-1988 
Iran-Iraq War (3). Approximately 10 years later, Khateri 
et al. evaluated survivors and found that they were suffering 
from respiratory (42.5%), ophthalmic (39.3%), and cutane-
ous (24.5%) complications (4). Mustard gas, or bis (2-chlo-
roethyl) sulfide, is an alkylating agent with low solubility in 
water and high solubility in fat (5, 6). In its pure form, it is a 
colorless and odorless liquid, but it may have a garlicky odor 
due to impurities (7). This substance can readily penetrate 
clothing and skin and can be absorbed through the skin or 
respiratory tract. In its penetration pathway, it damages tis-
sues and is then absorbed into the bloodstream. In the lungs, 
mustard gas can cause early and late complications (5). Early 
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and acute effects include epithelial necrosis, accumulation of 
secretions and atelectasis, bronchial obstruction, hypoventi-
lation, and hemorrhage (8). Chronic effects include chron-
ic bronchitis, fibrosis, asthma, and bronchiectasis. Fibrosis 
may appear several years after exposure and can be evalu-
ated by spirometry, diffusion capacity, and high-resolution 
computed tomography (HRCT) (9). It has also been shown 
that the incidence of lung cancer is higher in people exposed 
to mustard gas than the general population (10). HRCT is a 
powerful tool for the diagnosis of parenchymal and airway 
abnormalities (11).
Studies have reported varying results regarding the pul-
monary complications of exposure to mustard gas. Ghanei 
et al. used HRCT to evaluate people with a history of ex-
posure to various gases, and the most frequent abnormali-
ty was air trapping (38%) (12). Bagheri et al. examined 50 
people with a history of exposure to mustard gas. HRCT 
was abnormal in all patients, and the most frequent find-
ing was bronchial wall thickening, which was observed in 
all patients (13). Ghanei et al. also reported that bronchial 
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wall thickening was the most frequent finding, which was 
observed in 90% of mustard gas-exposed veterans. They 
found that air trapping (76%) and bronchiectasis (74%) were 
the next most frequent findings (14). However, Emad et al. 
reported that chronic bronchitis (58.8%) was the most com-
mon finding in mustard-exposed people and that bronchiec-
tasis was not so common (15).
In our study, we used high-resolution computed tomog-
raphy (HRCT) to assess the pulmonary complications after 
20 years of veterans of the Iran-Iraq War who were exposed 
to mustard gas.
MATERIALS AND METHODS
Patients
In this follow-up study, 200 Iranian veterans with a document-
ed history of exposure to mustard gas in the Iran-Iraq War and 
who showed acute or chronic respiratory symptoms were se-
lected as study patients. The patients were consecutively se-
lected from 500 veterans with the abovementioned conditions 
who were registered in a mustard gas exposure data bank.
The following data were collected: age, history of pre-ex-
posure respiratory illnesses, smoking history, current respira-
tory status, and symptoms at the time of exposure. Required 
data were obtained from the medical files available at the 
main university hospital in Yazd, Iran. All patients who were 
smokers, who had a history of respiratory disease before ex-
posure to mustard gas, and who had a history of occupation-
al exposure to respiratory contaminants were excluded from 
the study. All selected patients did not report any pulmonary 
problems prior to exposure to mustard gas. Most (76%) were 
between 15 and 20 years of age at the time of exposure.
HRCT
Patients completed a checklist of demographic data and re-
spiratory symptoms, after which HRCT was performed using 
one scanner for all selected patients (device: Shimadzu spiral 
CT scanner, model SCT-7800TX, Japan). HRCT images of 
1-mm slice thickness were obtained at 20-mm intervals. The 
images were taken in both deep inspiration and deep expi-
ration in the supine position. The non-contrast images were 
obtained with a window special for lung parenchyma (-100 
to -200), with a width of 1600-1800.
Images were interpreted by two independent expert ra-
diologists who were blinded to the study. Agreement was 
calculated by the kappa statistic. In cases of disagreement, a 
third radiologist interpreted the findings. A form containing 
demographic and radiologic information was designed for 
data collection. The first part included demographic data; the 
second part included data about HRCT. The lungs were di-
vided into five segments: left upper, left lower, right upper, 
right middle, and right lower. Six findings were considered 
most important: diffuse hyper-aeration, interstitial opacity, 
lung parenchymal opacity, bronchiectasis, local fibrosis, and 
sub-pleural air trapping.
Data were analyzed with statistical package for the social 
sciences (SPSS) version 20 software. The sample size was 
calculated by estimating prevalence in a population consid-
ering a type 1 error of 0.05, prevalence of 0.5, and 0.06 ac-
cepted absolute differences. The findings were reported as 
mean ± standard deviation. The range was reported. Also, 
the chi square test was used. P values less than 0.05 were 
considered statistically significant.
RESULTS
All patients were men, with a mean (± standard deviation) 
age of 38 (± 6.2) years (range: 32-78 years). They were ex-
posed to mustard gas about 20 years before (18.9 ± 1.3) 
during the Iran-Iraq War (1980-1988). HRCT examinations 
were obtained between January 2006 and February 2007 
for each patient. All had respiratory complaints of varying 
intensity, including chronic cough, dyspnea, suffocation, 
and hemoptysis. In 80 patients (40%), HRCT was normal. 
The other 120 patients (60%) had various HRCT findings. 
Table 1 shows the frequency of HRCT findings in the 
 patients. Diffuse hyper-aeration was the most frequent find-
ing, in 63 (52.5%) patients, followed by interstitial opac-
ity (41.7%), parenchymal opacity (21.7%), bronchiectasis 
(12.5%), sub-pleural air trapping (10.8%), and local fibrosis 
(8.3%).
Regardless of the type of lesion, the lower lobes in both 
lungs were more frequently affected than the upper lobes: on 
HRCT, 17 (14.2%) patients had abnormalities in the left low-
er lobe, 17 (14.2%) patients had abnormalities in the right 
lower lobe, 3 (2.5%) patients had abnormalities in the left 
upper lobe, and 4 (3.3%) patients had abnormalities in the 
right upper lobe. In 30 (25%) patients, all fields of both lungs 
were affected. Also, 30 (25%) patients had HRCT findings in 
both left upper lobe and right lower lobe segments. Table 2 
shows the frequency of HRCT findings regarding the various 
lung segments.
The patients were divided into three groups by age. The 
frequency of abnormalities was compared in different age 
ranges, but the difference between groups was not statistical-
ly significant (P = 0.9) (Table 3).
DISCUSSION
Mustard gas can have deleterious effects on the human body, 
among the most serious being respiratory effects. In the cur-
rent study, 200 Iranian veterans with respiratory symptoms 
who were exposed to mustard gas during the Iran-Iraq War 
Table 1. Frequency of HRCT findings in Iranian veterans 
who were exposed to mustard gas
HRCT finding Frequency (%)
Diffuse hyperaeration 63 (52.5)
Sub-pleural air trapping 13 (10.8)
Interstitial opacity 50 (41.7)
Local fibrosis 10 (8.3)
Bronchiectasis 15 (12.5)
Parenchymal opacity 26 (21.7)
(HRCT: high-resolution computed tomography)
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were assessed radiographically. We tried to omit other pre-
disposing factors that may cause HRCT abnormalities, such 
as smoking and occupational exposures. In the patients who 
entered the study, we did not identify any other predispos-
ing factors, such as infections, collagen vascular diseases, 
and cystic fibrosis. Patients were selected from veterans who 
were documented to be in the Iranian town of Shalamcheh 
(the site of large mustard gas attacks) during the war. The 
study population was young (mean age: 38 years); in most 
other studies in Iran, the mean age is similar.
In this study, we used HRCT to assess pulmonary abnor-
malities, because it can more accurately delineate lung anat-
omy and small airways than chest X-ray and conventional 
CT (3, 16). Also, in the follow-up of patients with interstitial 
lung diseases, HRCT is a standard method (17). In the cur-
rent study, 60% of patients had radiographic abnormalities, 
which was consistent with the study of Ghanei et al. in which 
62.8% of patients had HRCT abnormalities. In our study, 
diffuse hyper-aeration was the most frequent finding, which 
was consistent with other studies (13, 15). We found that in-
terstitial opacity and sub-pleural thickening were frequent as 
well. Interstitial opacity is important because it may show 
lung fibrosis and requires long-term follow-up. Air trapping 
is also important because it shows obstruction of small bron-
chioles and is probably a radiographic sign of bronchiolitis 
obliterans.
We found local fibrosis in about 8% of patients, which was 
similar to the studies of Emad et al. and Hafezi et al. (5, 15).
In most cases, lower lung lobes were most frequently af-
fected, which is probably due to the fact that lower lobes are 
larger than upper lobes.
CONCLUSION
We found a high frequency of HRCT abnormalities among 
mustard gas-exposed veterans, and most abnormalities 
were irreversible. Therefore, we recommend that periodic 
pulmonary assessments be performed for these patients. In 
our study, HRCT findings included diffuse hyper-aeration, 
interstitial opacity, parenchymal opacity, bronchiectasis, 
sub-pleural air trapping, and local fibrosis. Other areas that 
warrant further study in terms of patient exposure to mustard 
gas include the cellular effects of mustard gas and genetic 
markers indicating exposure to mustard gas.
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